Neuland Laboratories (NSE:NEULANDLAB) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:NEULANDLAB Neuland Laboratories Ltd NSE:NEULANDLAB
93 GF Score
Price ₹18,434.00
GF Value ₹16,103.17
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is Neuland Laboratories Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NSE:NEULANDLAB
93GF Score
Neuland Laboratories Ltd NSE:NEULANDLAB
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Neuland Laboratories (NSE:NEULANDLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Neuland Laboratories stock appears to be overvalued. The current stock price of ₹18,434.00 is trading 14.5% above its estimated GF Value™ of ₹16,103.17. GuruFocus considers Neuland Laboratories to be Modestly Overvalued.

Key valuation signals for NSE:NEULANDLAB:

  • Short Ratio:
  • GF Value™: ₹16,103.17 vs. price of ₹18,434.00 (14.5% above fair value)
  • GF Score™: 93/100 with 1 warning sign

No single metric tells the full story. See the NSE:NEULANDLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Neuland Laboratories Business Description

Other Exchanges 524558:India
Address Road No. 82, Jubilee Hills, Plot No. 573A-III, Phoenix IVY Building, 11th Floor (5th Office Level), Hyderabad, TG, IND, 500033
Neuland Laboratories Ltd is engaged in the manufacturing and selling of bulk drugs and caters to both the domestic and international markets. It is an API contract development and manufacturing organization (CDMO), supporting biotechnology and pharmaceutical companies in the design, development, and manufacturing of complex active pharmaceutical ingredients (APIs). The company develops small molecules and peptides for clinical trials and beyond, with the capacity to scale up through every stage of the product lifecycle to commercial manufacturing. Geographically, the group derives maximum revenue from its customers in India, followed by Europe, the USA and North America, and the Rest of the world.
93GF Score

Get the complete analysis for NSE:NEULANDLAB

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹18,434.00
Price
₹16,103.17
GF Value